Photodermatoses

Photodermatoses are disorders in which a skin irregularity or lesion occurs after exposure to ultraviolet radiation or visible light.

Quick Answer

What it is

Photodermatoses are disorders in which a skin irregularity or lesion occurs after exposure to ultraviolet radiation or visible light.

Key findings

  • Grade A: Pain-Free Sun Exposure Time (Afamelanotide)
  • Grade A: Phototoxic Reactions (Afamelanotide)
  • Grade A: Quality of Life (EPP) (Afamelanotide)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Photodermatoses

  • Supplements Studied:2
  • Research Trials:1
  • Total Participants:57
  • Top Supplement:Phlebodium aureum (C)
1 trials
57 ppts
2 supps · 4 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

500mg twice daily

Enhances cellular energy and DNA repair after UV damage; reduces skin cancer risk

8 studies | 500 participants
25-180mg daily (dose depends on condition)

Provides photoprotection; used for erythropoietic protoporphyria and PMLE

10 studies | 400 participants

Supporting Stack (Tier 2)

240-480mg daily (or 2 hours before sun exposure)

Fern extract with photoprotective properties; reduces sunburn cells and DNA damage

8 studies | 300 participants
400-800 IU daily

Antioxidant; protects skin from UV-induced free radical damage

6 studies | 250 participants
500-1000mg daily

Antioxidant; works synergistically with vitamin E for photoprotection

5 studies | 200 participants
2-4g EPA+DHA daily

Anti-inflammatory; may increase time to sunburn

4 studies | 150 participants

How It Works

Photodermatoses are skin conditions caused or worsened by exposure to light, usually sunlight. They range from common conditions like polymorphous light eruption to rare genetic disorders.

COMMON TYPES:

Polymorphous Light Eruption (PMLE): Most common; itchy rash after sun exposure
Solar urticaria: Hives from sun exposure
Chronic actinic dermatitis: Severe sun sensitivity, usually in older men
Erythropoietic protoporphyria (EPP): Genetic; severe pain with sun exposure
Drug-induced photosensitivity: From medications

SYMPTOMS:

Rash, bumps, or hives on sun-exposed skin
Itching, burning, or stinging
Redness
Blisters (severe cases)
Occurs shortly after sun exposure

COMMON PHOTOSENSITIZING MEDICATIONS:

Tetracyclines (doxycycline)
Thiazide diuretics
NSAIDs
Sulfonamides
Some antipsychotics
Some antidepressants

PREVENTION:

Strict sun protection (sunscreen SPF 50+, reapply)
Protective clothing (UPF-rated)
Avoid peak sun hours (10am-4pm)
Seek shade
Review medications for photosensitizers

MEDICAL TREATMENTS:

Desensitization phototherapy (for PMLE)
Topical corticosteroids for rash
Antihistamines for itching
Afamelanotide (for EPP)

* Nicotinamide has strong evidence for reducing UV damage.

* Beta-carotene provides some photoprotection.

* Polypodium leucotomos is an oral photoprotectant.

Expected timeline: Supplements should be taken consistently; take beta-carotene for 10 weeks before sun season for EPP. Nicotinamide provides ongoing protection.

Generated from peer-reviewed researchSchema v2.0

Supplements for Photodermatoses

Sorted by strength of evidence

Detailed Outcomes

A
Pain-Free Sun Exposure Time
69.4 vs 40.8 hours median (US trial); 6.0 vs 0.8 hours (EU trial)
largeWorsens
A
Phototoxic Reactions
77 vs 146 reactions over 9 months treatment
largeImproves
A
Quality of Life (EPP)
Improved outdoor activity participation
moderateImproves
?
Polymorphic Light Eruptions
1 study
Improves

Research Citations (35)

German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP)
(2025)
PMID: 40082741
Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective.
(2025)
PMID: 40692281
Treatment Advances in Vitiligo: An Updated Review.
(2025)
PMID: 40117616
Afamelanotide in protoporphyria and other skin diseases: a review
(2024)
PMID: 38715490
Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
(2024)
PMID: 38417409
A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo.
(2024)
PMID: 38454597
Afamelanotide in protoporphyria and other skin diseases: a review.
(2024)
PMID: 38784937
A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial.
(2023)
PMID: 37496004
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria.
(2023)
PMID: 37109595
Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria
(2021)
PMID: 33486349

Related Conditions

Vitiligo

2 shared supplements · 5 outcomes

Vitiligo is a skin condition characterized by patches of skin losing their skin pigment. It's cause isn't clear, but genetic risk factors and a family history of autoimmune disorders are thought to contribute to its development.

Skin Health

2 shared supplements · 110 outcomes

Skin health refers to the integrity of skin function. Healthy skin maintains a barrier between the external environment and the inside of the body, and is characterized as smooth, moisturized, clear of blemishes, and radiant.

Psoriasis

1 shared supplement · 14 outcomes

Psoriasis is a chronic skin disease that causes patches of thick, red, scaly skin on various parts of the body. Its cause is unknown and symptoms tend to wax and wane over time.

Polymorphous Light Eruption

1 shared supplement · 1 outcomes

Polymorphic light eruptions, also known as sun allergy or sun poisoning, are skin rashes that can be caused by sun exposure in individuals who are sensitive to sunlight. The rash usually appears as small, inflamed bumps or patches of skin that are slightly raised.

Immune Health

1 shared supplement · 409 outcomes

Immune health refers to the body's ability to resist potentially harmful microorganisms such as viruses and bacteria, and includes both innate and acquired immunity.

Dementia

1 shared supplement · 30 outcomes

Dementia is a term that refers to a decline in cognitive function that interferes with daily life. Dementia can affect language, memory, visual perception, problem-solving, and focus. People with dementia may lose their ability to do everyday activities, including bathing, dressing, eating, and using the bathroom.